Ischemix Employee Directory
Biotechnology ResearchMassachusetts, United States2-10 Employees
Ischemix is a privately held biotechnology company based in Maynard, Massachusetts. It develops cytoprotective compounds intended to prevent and treat serious conditions affecting the kidney, heart, and other organ systems. The company operates within the biotechnology research sector, aiming to address organ injury through its lead molecules. In January 2023, Ischemix announced the appointment of David A. DeWahl, Jr. as President and Chief Executive Officer. This leadership change reflects a recent development in the company's public updates.